Individuals suffering from food allergies now have access to a medication that can potentially avert serious consequences. This medication, which has been available for twenty years, has received approval from the FDA. Xolair (omalizumab) by Roche and Novartis is the first food allergy treatment sanctioned to dimin...
Find MoreAllergies are on the rise globally, affecting millions of people and significantly impacting their quality of life. The ability to accurately diagnose and manage allergies is crucial for both patients and healthcare providers. With the rising prevalence of allergy, the demand for Allergy Diagnostics has increased m...
Find MoreFood allergies are becoming a global concern. According to the World Allergy Organization, "food allergy impacted around 2.5% of the general population, but prevalence figures ranged from 1% to 10%." The increasing incidence of food allergies is raising food safety and public health issues and it is estimated that ...
Find MoreFood Allergies is a major concern for a wide spectrum of populations globally. According to the World Allergy Organization, “food allergy affected approximately 2.5% of the general population, but the spread of prevalence data was wide, ranging from 1% to 10%.” According to the Centers for Disease Control and Preve...
Find MoreLive Coverage of ASCO 2024 Visit Now for Real-Time Insights and Analytical, Impactful Updates!